4//SEC Filing
Chawla Lakhmir S 4
Accession 0000920465-20-000075
CIK 0000920465other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:05 PM ET
Size
7.0 KB
Accession
0000920465-20-000075
Insider Transaction Report
Form 4
Chawla Lakhmir S
Chief Medical Officer
Transactions
- Award
Common Stock
2020-05-15$5.86/sh+335$1,963→ 9,451 total - Award
Stock Option (Right to Buy)
2020-05-15+335→ 335 totalExercise: $6.89Exp: 2030-05-15→ Common Stock (335 underlying)
Footnotes (2)
- [F1]These shares were acquired on 05/15/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001646626
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:05 PM ET
- Size
- 7.0 KB